RenovoRx Inc (RNXT)
1.243
+0.03
(+2.73%)
USD |
NASDAQ |
Apr 26, 16:00
1.28
+0.04
(+2.98%)
After-Hours: 20:00
RenovoRx Shareholders Equity (Quarterly): -3.00M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.00M |
| September 30, 2023 | 0.006M |
| June 30, 2023 | 1.188M |
| March 31, 2023 | 3.256M |
| December 31, 2022 | 6.163M |
| September 30, 2022 | 8.148M |
| June 30, 2022 | 10.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 12.54M |
| December 31, 2021 | 15.35M |
| September 30, 2021 | 17.55M |
| June 30, 2021 | -17.06M |
| March 31, 2021 | -15.76M |
| December 31, 2020 | -14.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-17.06M
Minimum
Jun 2021
17.55M
Maximum
Sep 2021
1.834M
Average
3.256M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Annexon Inc | 250.56M |
| Longeveron Inc | 6.741M |
| MiNK Therapeutics Inc | -18.06M |
| Adlai Nortye Ltd | -317.54M |
| Telomir Pharmaceuticals Inc | 3.438M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.466M |
| Total Liabilities (Quarterly) | 4.466M |